Sign Up to like & get
recommendations!
0
Published in 2021 at "Bipolar disorders"
DOI: 10.1111/bdi.13129
Abstract: Treatment-resistant bipolar depression (TRBD) is a significant but less well-defined and quantified condition compared to treatment-resistant depression (TRD, unipolarity implied). Ketamine, a novel glutamatergic anesthetic agent repurposed as a rapid-acting antidepressant, is considered a third-line…
read more here.
Keywords:
depression;
treatment resistant;
bipolar depression;
treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Bipolar Disorders"
DOI: 10.1111/bdi.13262
Abstract: BACKGROUND Management of treatment-resistant bipolar mania has not been discussed much in the literature. The underlying degenerative neurological disorders could be one of the reasons for treatment resistance. METHODS A 27-year-old single male presented with…
read more here.
Keywords:
treatment;
bipolar mania;
resistant bipolar;
treatment resistant ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Bipolar Disorders"
DOI: 10.1111/bdi.13324
Abstract: Ketamine is a novel drug used for treatment- resistant depression. The initial randomized controlled trials (RCTs) established intravenous (IV) ketamine's rapid antidepressant effects for refrac-tory major depression, leading to its widespread use. However, the data…
read more here.
Keywords:
bipolar depression;
ketamine;
depression;
treatment resistant ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s325000
Abstract: Purpose Bipolar disorder is a chronic and recurrent condition often associated with treatment resistance and suicidality. There is an unmet need for effective treatment in this group of patients. Ketamine has been demonstrated to have…
read more here.
Keywords:
treatment;
resistant bipolar;
treatment resistant;
bipolar depression ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Medicina"
DOI: 10.3390/medicina56020067
Abstract: The current psychopharmacological treatment approaches for major depression focus on monoaminergic interventions, which are ineffective in a large proportion of patients. Globally, treatment-resistant bipolar depression (TRBD) affects up to 33% of depressive patients receiving treatment.…
read more here.
Keywords:
symptomatology;
depression;
treatment resistant;
treatment ... See more keywords